Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
BALPHARMA | NSE
-4.36
-3.31%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
19/09/2024
127.24
131.60
134.50
125.02
Bal Pharma Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers prescription drugs generics OTC products intravenous infusion products and bulk actives. It provides anti-infectives pain management respiratory care and women's health products under the Aziwin Ebay Balvibe MNF Ocium and Monogesic Plus Gel brands; diabetic care products under the Diabend and Diabend M Group brands; herbal/ayurvedic preparations targeting conditions such as prostrate enlargement renal calculi male infertility women health etc. under the Stonex Ashwamed Prostowin Suswas Menoleap and Ayursulin brands; anti-hypertensive anti-lipidemic and anti-obese products; skin care and bone health products; and cardiac care products under the Secremet and Servace brands. In addition the company offers a range of APIs for therapeutic areas such as anti-histamine platelet inhibitor anti-diabetic anti convulsant urinary incontinence neuropathic pain anti-allergy anti-inflammatory diuretic acne treatment etc.; and various formulations. Further it engages in the treatment of gastrointestinal disorders; and piles fistula and constipation. Bal Pharma Limited was incorporated in 1987 and is based in Bengaluru India.
View LessLow Market Beta (-0.4 to 0.8)
Price Below SMA10D
Microcap (<300M USD)
High Debt to Equity (> 0.75)
Weak Operating Margin (< 10%)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
32.6%1 month
73.5%3 months
52.1%6 months
54.6%27.01
-
3.13
2.02
0.44
10.52
1.03
-
325.85M
2.01B
24.06M
0.87
5.43
166.70
5.60
11.20
-
-
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
17.68
Range1M
44.98
Range3M
48.80
Rel. volume
0.09
Price X volume
2.92M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Vaishali Pharma Limited | VAISHALI | Drug Manufacturers-Specialty & Generic | 192.25 | 2.06B | -1.98% | 333.23 | 31.49% |
Mangalam Drugs & Organics Limited | MANGALAM | Drug Manufacturers-Specialty & Generic | 127.32 | 2.02B | -6.02% | n/a | 72.53% |
Krebs Biochemicals & Industries Limited | KREBSBIO | Drug Manufacturers-Specialty & Generic | 90.59 | 1.96B | -2.00% | n/a | -162.25% |
Bafna Pharmaceuticals Limited | BAFNAPH | Drug Manufacturers-Specialty & Generic | 79.14 | 1.89B | 658.33 | 30.17% | |
Aarey Drugs & Pharmaceuticals Limited | AAREYDRUGS | Drug Manufacturers-Specialty & Generic | 66.39 | 1.86B | -3.31% | 34.02 | 23.61% |
Lasa Supergenerics Limited | LASA | Drug Manufacturers-Specialty & Generic | 27.12 | 1.36B | -4.57% | n/a | 22.84% |
Ind-Swift Limited | INDSWFTLTD | Drug Manufacturers-Specialty & Generic | 23.81 | 1.29B | -1.37% | 3.23 | -146.78% |
Biofil Chemicals and Pharmaceuticals Limited | BIOFILCHEM | Drug Manufacturers-Specialty & Generic | 77.68 | 1.26B | -7.23% | 197.64 | 2.41% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 166.42 | 1.85B | -3.27% | 49.20 | 4.88% |
Cubex Tubings Limited | CUBEXTUB | Copper | 93.74 | 1.34B | -3.01% | 34.07 | 21.78% |
Madhav Copper Limited | MCL | Copper | 36.42 | 1.02B | -1.33% | n/a | 32.70% |
Sagardeep Alloys Limited | SAGARDEEP | Copper | 28.12 | 483.23M | 88.75 | 43.14% | |
Heads UP Ventures Limited | HEADSUP | Apparel Retail | 14.67 | 331.86M | -1.48% | n/a | 0.00% |
Suumaya Industries Limited | SUULD | Apparel Retail | 4.93 | 296.65M | -2.38% | n/a | -118.72% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 10.52 | 23.29 | Cheaper |
Ent. to Revenue | 1.03 | 12.02 | Cheaper |
PE Ratio | 27.01 | 47.84 | Cheaper |
Price to Book | 3.13 | 6.55 | Cheaper |
Dividend Yield | 0.87 | 0.59 | Leader |
Std. Deviation (3M) | 52.12 | 40.95 | Riskier |
Debt to Equity | 2.02 | 0.34 | Expensive |
Debt to Assets | 0.44 | 0.17 | Expensive |
Market Cap | 2.01B | 286.13B | Emerging |